Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04907396 · ClinicalTrials.gov registry record
International Weight Control Registry
A clinical trial of Obesity and Overweight, sponsored by Tufts University.
- Recruiting
- Registry status
- 100,000
- Enrollment target
- 7
- Study locations
NCT04907396: Recruiting study of Obesity and Overweight, sponsored by Tufts University.
NCT04907396 is a study of Obesity and Overweight that is actively recruiting participants, run by Tufts University. The registered enrollment target is 100,000 participants, above the 724-participant average among 1,053 other Obesity trials with a reported enrollment target (13712% higher). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04907396, a study of Obesity and Overweight, is actively recruiting participants, sponsored by Tufts University.
- RECRUITING
- Registry status
- 100,000 participants
- Enrollment target
- 7
- Study locations
Study Summary
The IWCR is a global scientific study aimed at better understanding the opportunities and barriers for reducing the prevalence of obesity by collecting information from people who have experience with weight management in their everyday lives. The investigators seek to gather information on a wide range of weight management experiences, ranging from weight loss and weight loss maintenance to weight gain and inability to lose weight.
Conditions Studied
Study Locations (7)
Alabama
- University of Alabama at Birmingham - Birmingham
Colorado
- University of Colorado, Denver - Denver
Kansas
- University of Kansas Medical Center - Kansas City
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
Massachusetts
- Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University - Boston
New Hampshire
- University of New Hampshire - Durham
New York
- United States Military Academy, West Point - West Point
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100,000 participants |
| Start Date | 2020-12-10 |
| Est. Completion | 2025-12-01 |
What NCT04907396 shows while recruiting
NCT04907396 is an observational study that tracks outcomes without assigning an intervention. Its 100,000 participants enrollment target places it among the larger protocols in the corpus, above the 724-participant average among 1,053 other Obesity trials with a reported enrollment target (13712% higher).
The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 0 interventions.
NCT04907396 lists 7 locations in 7 states (Alabama, Colorado, Kansas).
Frequently Asked Questions
What is clinical trial NCT04907396 about?
NCT04907396 is a clinical study titled "International Weight Control Registry". The IWCR is a global scientific study aimed at better understanding the opportunities and barriers for reducing the prevalence of obesity by collecting information from people who have experience with weight management in their everyday lives. The investigators seek to gather information on a wide r...
What is the current status of trial NCT04907396?
This trial is currently recruiting. The enrollment target is 100,000 participants. The study started on 2020-12-10. Estimated completion is 2025-12-01.
What conditions does trial NCT04907396 study?
This clinical trial studies the following conditions: Obesity, Overweight, Weight Loss.
Who is sponsoring clinical trial NCT04907396?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04907396 being conducted?
This trial has 7 study locations across Alabama, Colorado, Kansas, Louisiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04907396's enrollment target sits among peer trials
100,000 2nd of 1053 higher than 1,051 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02620852 · 100,000 participants · NA
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- NCT03277365 · 100,000 participants · NA
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
- NCT04281823 · 100,000 participants
DeBakey Cardiovascular Magnetic Resonance Study
- NCT04869111 · 100,000 participants · NA
The BrainHealth Project
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI